BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3014907)

  • 1. Significance of production of peptide leukotrienes in murine traumatic shock.
    Craft DV; Lefer DJ; Hock CE; Lefer AM
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H80-5. PubMed ID: 3014907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat.
    Foster A; Letts G; Charleson S; Fitzsimmons B; Blacklock B; Rokach J
    J Immunol; 1988 Nov; 141(10):3544-50. PubMed ID: 2846689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of peptide leukotrienes in endotoxin shock.
    Hagmann W; Denzlinger C; Keppler D
    FEBS Lett; 1985 Jan; 180(2):309-13. PubMed ID: 3967766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene C4 metabolism by hepatoma cells and liver.
    Keppler D; Huber M; Weckbecker G; Hagmann W; Denzlinger C; Guhlmann A
    Adv Enzyme Regul; 1987; 26():211-24. PubMed ID: 2890280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4.
    Hagmann W; Denzlinger C; Rapp S; Weckbecker G; Keppler D
    Prostaglandins; 1986 Feb; 31(2):239-51. PubMed ID: 3515428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.
    Stene DO; Murphy RC
    J Biol Chem; 1988 Feb; 263(6):2773-8. PubMed ID: 2830262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog.
    Pfeifer CA; Bottoms GD; Johnson MA; Fessler J
    Circ Shock; 1991 Feb; 33(2):68-83. PubMed ID: 1675594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
    Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
    Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of in-vivo omega-oxidation of peptide leukotrienes in the rat: biliary excretion of 20-CO2H N-acetyl LTE4.
    Foster A; Fitzsimmons B; Rokach J; Letts G
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1237-45. PubMed ID: 2825679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of sinusoidal uptake and biliary excretion of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1990 Jul; 191(1):251-5. PubMed ID: 2165907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of beta-oxidation products as potential leukotriene metabolites and their detection in bile of anesthetized rat.
    Delorme D; Foster A; Girard Y; Rokach J
    Prostaglandins; 1988 Sep; 36(3):291-302. PubMed ID: 3237994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical considerations in the development of an assay for sulfidopeptide leukotrienes in plasma.
    Heavey DJ; Soberman RJ; Lewis RA; Spur B; Austen KF
    Prostaglandins; 1987 May; 33(5):693-708. PubMed ID: 3035620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene biosynthesis and metabolism detected by the combined use of HPLC and radioimmunoassay.
    Beaubien BC; Tippins JR; Morris HR
    Biochem Biophys Res Commun; 1984 Nov; 125(1):97-104. PubMed ID: 6095847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of cysteinyl leukotrienes by the isolated perfused rat kidney.
    Fauler J; Wiemeyer A; Yoshizawa M; Schurek HJ; Frolich JC
    Prostaglandins; 1991 Sep; 42(3):239-49. PubMed ID: 1664114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperoxic lung damage in mice: appearance and bioconversion of peptide leukotrienes.
    Smith LJ; Shamsuddin M; Anderson J; Hsueh W
    J Appl Physiol (1985); 1988 Mar; 64(3):944-51. PubMed ID: 2835352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene D4 and E4 formation by plasma membrane bound enzymes.
    Kuo CG; Lewis MT; Jakschik BA
    Prostaglandins; 1984 Dec; 28(6):929-38. PubMed ID: 6151716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of reversed phase high performance liquid chromatography to the analysis of sulphidopeptide leukotrienes in pig bile.
    Tagari P; Ethier D; Ford-Hutchinson A; Cirino M
    Biomed Chromatogr; 1990 Jan; 4(1):39-42. PubMed ID: 2310841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene E4 elimination and metabolism in normal human subjects.
    Sala A; Voelkel N; Maclouf J; Murphy RC
    J Biol Chem; 1990 Dec; 265(35):21771-8. PubMed ID: 2174886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.